15-48504949-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000138.5(FBN1):​c.1960+76G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.057 in 1,576,856 control chromosomes in the GnomAD database, including 2,966 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.050 ( 278 hom., cov: 33)
Exomes 𝑓: 0.058 ( 2688 hom. )

Consequence

FBN1
NM_000138.5 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.0450

Publications

5 publications found
Variant links:
Genes affected
FBN1 (HGNC:3603): (fibrillin 1) This gene encodes a member of the fibrillin family of proteins. The encoded preproprotein is proteolytically processed to generate two proteins including the extracellular matrix component fibrillin-1 and the protein hormone asprosin. Fibrillin-1 is an extracellular matrix glycoprotein that serves as a structural component of calcium-binding microfibrils. These microfibrils provide force-bearing structural support in elastic and nonelastic connective tissue throughout the body. Asprosin, secreted by white adipose tissue, has been shown to regulate glucose homeostasis. Mutations in this gene are associated with Marfan syndrome and the related MASS phenotype, as well as ectopia lentis syndrome, Weill-Marchesani syndrome, Shprintzen-Goldberg syndrome and neonatal progeroid syndrome. [provided by RefSeq, Apr 2016]
FBN1 Gene-Disease associations (from GenCC):
  • familial thoracic aortic aneurysm and aortic dissection
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • Marfan syndrome
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, ClinGen, G2P, PanelApp Australia, Orphanet, Ambry Genetics
  • Acromicric dysplasia
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics
  • progeroid and marfanoid aspect-lipodystrophy syndrome
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet
  • stiff skin syndrome
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • Weill-Marchesani syndrome 2, dominant
    Inheritance: AD Classification: STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • geleophysic dysplasia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • isolated ectopia lentis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • neonatal Marfan syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Weill-Marchesani syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • ectopia lentis 1, isolated, autosomal dominant
    Inheritance: AD Classification: LIMITED Submitted by: G2P
  • Shprintzen-Goldberg syndrome
    Inheritance: AD, Unknown Classification: LIMITED, NO_KNOWN Submitted by: ClinGen, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 15-48504949-C-T is Benign according to our data. Variant chr15-48504949-C-T is described in ClinVar as Benign. ClinVar VariationId is 674484.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.143 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FBN1NM_000138.5 linkc.1960+76G>A intron_variant Intron 16 of 65 ENST00000316623.10 NP_000129.3 P35555
FBN1NM_001406716.1 linkc.1960+76G>A intron_variant Intron 15 of 64 NP_001393645.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FBN1ENST00000316623.10 linkc.1960+76G>A intron_variant Intron 16 of 65 1 NM_000138.5 ENSP00000325527.5 P35555

Frequencies

GnomAD3 genomes
AF:
0.0499
AC:
7595
AN:
152096
Hom.:
277
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0133
Gnomad AMI
AF:
0.0670
Gnomad AMR
AF:
0.0648
Gnomad ASJ
AF:
0.0576
Gnomad EAS
AF:
0.153
Gnomad SAS
AF:
0.0900
Gnomad FIN
AF:
0.0742
Gnomad MID
AF:
0.0414
Gnomad NFE
AF:
0.0535
Gnomad OTH
AF:
0.0607
GnomAD4 exome
AF:
0.0578
AC:
82298
AN:
1424642
Hom.:
2688
AF XY:
0.0584
AC XY:
41521
AN XY:
711284
show subpopulations
African (AFR)
AF:
0.0102
AC:
334
AN:
32678
American (AMR)
AF:
0.0823
AC:
3677
AN:
44658
Ashkenazi Jewish (ASJ)
AF:
0.0589
AC:
1524
AN:
25860
East Asian (EAS)
AF:
0.139
AC:
5470
AN:
39460
South Asian (SAS)
AF:
0.0837
AC:
7144
AN:
85354
European-Finnish (FIN)
AF:
0.0796
AC:
4234
AN:
53168
Middle Eastern (MID)
AF:
0.0395
AC:
225
AN:
5698
European-Non Finnish (NFE)
AF:
0.0518
AC:
55889
AN:
1078654
Other (OTH)
AF:
0.0643
AC:
3801
AN:
59112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
3947
7893
11840
15786
19733
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2166
4332
6498
8664
10830
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0499
AC:
7596
AN:
152214
Hom.:
278
Cov.:
33
AF XY:
0.0512
AC XY:
3812
AN XY:
74424
show subpopulations
African (AFR)
AF:
0.0132
AC:
549
AN:
41538
American (AMR)
AF:
0.0648
AC:
991
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.0576
AC:
200
AN:
3470
East Asian (EAS)
AF:
0.152
AC:
787
AN:
5186
South Asian (SAS)
AF:
0.0885
AC:
426
AN:
4816
European-Finnish (FIN)
AF:
0.0742
AC:
787
AN:
10600
Middle Eastern (MID)
AF:
0.0479
AC:
14
AN:
292
European-Non Finnish (NFE)
AF:
0.0535
AC:
3641
AN:
67996
Other (OTH)
AF:
0.0662
AC:
140
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
367
734
1102
1469
1836
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
90
180
270
360
450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0524
Hom.:
314
Bravo
AF:
0.0473
Asia WGS
AF:
0.164
AC:
570
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 14, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
2.5
DANN
Benign
0.31
PhyloP100
-0.045
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17361868; hg19: chr15-48797146; COSMIC: COSV107345577; API